Impact of the Diagnosis of Celiac Disease
1 other identifier
observational
760
1 country
1
Brief Summary
The main purpose of this study is to assess the impact of the diagnosis of celiac disease on general health, healthcare resource utilization, quality of life and lifestyle. We hypothesize that diagnosis and subsequent dietary treatment may have positive impact on these variables.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 7, 2010
CompletedFirst Posted
Study publicly available on registry
June 16, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedApril 21, 2016
April 1, 2016
9.2 years
June 7, 2010
April 19, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychological General Well-Being (PGWB) Index
Health-related quality of life and self-perceived health are evaluated at diagnosis and after five years on dietary treatment by using structured questionnaire
5 years
Secondary Outcomes (6)
healthcare resource utilization
5 years
Gastrointestinal Symptoms Rating Scale (GSRS)
5 years
dietary compliance
5 years
weight
5 years
height
5 years
- +1 more secondary outcomes
Eligibility Criteria
All new members with biopsy-proven celiac disease joining the Finnish Celiac Society.
You may qualify if:
- diagnosis within one year
- biopsy-proven diagnosis
You may not qualify if:
- Celiac disease diagnosis previously than within one year
- No biopsy-proven diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tampere University Hospitallead
- Tampere Universitycollaborator
- Finnish Celiac Societycollaborator
Study Sites (1)
Pediatric Research Centre, University of Tampere, Tampere University Hospital
Tampere, Pirkanmaa, 33014, Finland
Related Publications (4)
Ukkola A, Kurppa K, Collin P, Huhtala H, Forma L, Kekkonen L, Maki M, Kaukinen K. Use of health care services and pharmaceutical agents in coeliac disease: a prospective nationwide study. BMC Gastroenterol. 2012 Sep 27;12:136. doi: 10.1186/1471-230X-12-136.
PMID: 23016889DERIVEDKinos S, Kurppa K, Ukkola A, Collin P, Lahdeaho ML, Huhtala H, Kekkonen L, Maki M, Kaukinen K. Burden of illness in screen-detected children with celiac disease and their families. J Pediatr Gastroenterol Nutr. 2012 Oct;55(4):412-6. doi: 10.1097/MPG.0b013e31825f18ff.
PMID: 22614110DERIVEDUkkola A, Maki M, Kurppa K, Collin P, Huhtala H, Kekkonen L, Kaukinen K. Changes in body mass index on a gluten-free diet in coeliac disease: a nationwide study. Eur J Intern Med. 2012 Jun;23(4):384-8. doi: 10.1016/j.ejim.2011.12.012. Epub 2012 Jan 28.
PMID: 22560391DERIVEDUkkola A, Maki M, Kurppa K, Collin P, Huhtala H, Kekkonen L, Kaukinen K. Patients' experiences and perceptions of living with coeliac disease - implications for optimizing care. J Gastrointestin Liver Dis. 2012 Mar;21(1):17-22.
PMID: 22457855DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D, pH.D, Pediatrician
Study Record Dates
First Submitted
June 7, 2010
First Posted
June 16, 2010
Study Start
February 1, 2007
Primary Completion
April 1, 2016
Study Completion
April 1, 2016
Last Updated
April 21, 2016
Record last verified: 2016-04